Bullish Case: New strategic hire in investor relations, positive NUPLAZID data, and licensing deals could increase revenues and investor interest in the company. Trofinetide launch driving growth.


Show historical bullish cases

Bearish Case: Flat stock price action, very low implied volatility indicating lack of investor interest, and upcoming management change create uncertainty.


Show historical bearish cases

Takeaway: While ACAD has growth opportunities, the stock lacks momentum currently. The upcoming R&D leadership change adds complexity. Need to monitor licensing deals, pipeline updates, and investor engagement for signs of renewed interest. I integrated information about the new strategic investor relations hire, the CEO's stock sales, trofinetide licensing, and flat recent price action with low implied volatility. I tried to accurately estimate probabilities of potential outcomes based on the available data. Going forward, it will be important to watch for developments that could shift investor perceptions and move the stock price. Please let me know if you would like me to clarify or expand on any part of this analysis.


Show historical takeaways

Potential Outcomes:

1. 50% chance revenues increase from trofinetide launch and new licenses.

2. 30% chance flat trading continues due to low implied volatility.

3. 20% chance positive pipeline data boosts stock.


November 28, 2023


Acadia Pharmaceuticals Forecast

[ACAD]  Acadia Pharmaceuticals
Price Forecast: NEUTRAL    Price Action: RANDOM (?)



Make More Profitable Trades with ACAD Forecasts + Trading Strategies







ACAD Balanced News:












Become a more profitable trader with AI optimized trading strategies




Correlated Stock Forecasts

Assets that tend to move strongly with ACAD



TOL Forecast + Options Trading Strategies   [TOL]  Toll Brothers (0.94)


ROM Forecast + Options Trading Strategies   [ROM]  ProShares Ultra Technology (0.9)


SMH Forecast + Options Trading Strategies   [SMH]  VanEck Vectors Semiconductor (0.89)


AAPL Forecast + Options Trading Strategies   [AAPL]  Apple (0.89)


LIN Forecast + Options Trading Strategies   [LIN]  Linde (0.82)



Uncorrelated Stock Forecasts

Assets with little price relationship to ACAD



JNK Forecast + Options Trading Strategies   [JNK]  SPDR Bloomberg Barclays High Yield Bond (-0.06)


UYG Forecast + Options Trading Strategies   [UYG]  ProShares Ultra Financials (-0.08)


REM Forecast + Options Trading Strategies   [REM]  iShares Mortgage Real Est (-0.11)


APTV Forecast + Options Trading Strategies   [APTV]  Aptiv (-0.12)


UMC Forecast + Options Trading Strategies   [UMC]  United Micro Electronics (-0.12)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against ACAD



FL Forecast + Options Trading Strategies   [FL]  Foot Locker (-0.62)


CVX Forecast + Options Trading Strategies   [CVX]  Chevron (-0.64)


BL Forecast + Options Trading Strategies   [BL]  BlackLine (-0.67)


EE Forecast + Options Trading Strategies   [EE]  Excelerate Energy (-0.69)


SPXS Forecast + Options Trading Strategies   [SPXS]  Direxion Daily S&P 500 Bear 3X Shares (-0.91)